Physiological effects of dietary PIPS soybean-derived phospholipid in obese zucker (fa/fa) rats

Bungo Shirouchi, Koji Nagao, Kenta Furuya, Masatoshi Shiojiri, Xiaoli Liu, Teruyoshi Yanagita

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

The effects of soybean-derived phospholipid, PIPS NAGASETM (PIPS), on obesity-induced diseases were studied in obese rats. Dietary PIPS alleviated hepatomegaly and fatty liver in the rats. These effects were attributable to reduced lipogenesis and enhanced lipolysis in the liver. The results suggest that PIPS can be useful as a dietary component that would reduce the risk of lifestyle-related diseases.

Original languageEnglish
Pages (from-to)2333-2335
Number of pages3
JournalBioscience, Biotechnology and Biochemistry
Volume74
Issue number11
DOIs
Publication statusPublished - Dec 10 2010
Externally publishedYes

Fingerprint

Soybeans
Liver
Rats
Phospholipids
Lipogenesis
Hepatomegaly
Lipolysis
Fatty Liver
Life Style
Obesity

All Science Journal Classification (ASJC) codes

  • Biotechnology
  • Analytical Chemistry
  • Biochemistry
  • Applied Microbiology and Biotechnology
  • Molecular Biology
  • Organic Chemistry

Cite this

Physiological effects of dietary PIPS soybean-derived phospholipid in obese zucker (fa/fa) rats. / Shirouchi, Bungo; Nagao, Koji; Furuya, Kenta; Shiojiri, Masatoshi; Liu, Xiaoli; Yanagita, Teruyoshi.

In: Bioscience, Biotechnology and Biochemistry, Vol. 74, No. 11, 10.12.2010, p. 2333-2335.

Research output: Contribution to journalArticle

Shirouchi, Bungo ; Nagao, Koji ; Furuya, Kenta ; Shiojiri, Masatoshi ; Liu, Xiaoli ; Yanagita, Teruyoshi. / Physiological effects of dietary PIPS soybean-derived phospholipid in obese zucker (fa/fa) rats. In: Bioscience, Biotechnology and Biochemistry. 2010 ; Vol. 74, No. 11. pp. 2333-2335.
@article{8dcbc0ccdc6d4337888327c30688575f,
title = "Physiological effects of dietary PIPS soybean-derived phospholipid in obese zucker (fa/fa) rats",
abstract = "The effects of soybean-derived phospholipid, PIPS NAGASETM (PIPS), on obesity-induced diseases were studied in obese rats. Dietary PIPS alleviated hepatomegaly and fatty liver in the rats. These effects were attributable to reduced lipogenesis and enhanced lipolysis in the liver. The results suggest that PIPS can be useful as a dietary component that would reduce the risk of lifestyle-related diseases.",
author = "Bungo Shirouchi and Koji Nagao and Kenta Furuya and Masatoshi Shiojiri and Xiaoli Liu and Teruyoshi Yanagita",
year = "2010",
month = "12",
day = "10",
doi = "10.1271/bbb.100408",
language = "English",
volume = "74",
pages = "2333--2335",
journal = "Bioscience, Biotechnology and Biochemistry",
issn = "0916-8451",
publisher = "Japan Society for Bioscience Biotechnology and Agrochemistry",
number = "11",

}

TY - JOUR

T1 - Physiological effects of dietary PIPS soybean-derived phospholipid in obese zucker (fa/fa) rats

AU - Shirouchi, Bungo

AU - Nagao, Koji

AU - Furuya, Kenta

AU - Shiojiri, Masatoshi

AU - Liu, Xiaoli

AU - Yanagita, Teruyoshi

PY - 2010/12/10

Y1 - 2010/12/10

N2 - The effects of soybean-derived phospholipid, PIPS NAGASETM (PIPS), on obesity-induced diseases were studied in obese rats. Dietary PIPS alleviated hepatomegaly and fatty liver in the rats. These effects were attributable to reduced lipogenesis and enhanced lipolysis in the liver. The results suggest that PIPS can be useful as a dietary component that would reduce the risk of lifestyle-related diseases.

AB - The effects of soybean-derived phospholipid, PIPS NAGASETM (PIPS), on obesity-induced diseases were studied in obese rats. Dietary PIPS alleviated hepatomegaly and fatty liver in the rats. These effects were attributable to reduced lipogenesis and enhanced lipolysis in the liver. The results suggest that PIPS can be useful as a dietary component that would reduce the risk of lifestyle-related diseases.

UR - http://www.scopus.com/inward/record.url?scp=78649800056&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78649800056&partnerID=8YFLogxK

U2 - 10.1271/bbb.100408

DO - 10.1271/bbb.100408

M3 - Article

C2 - 21071860

AN - SCOPUS:78649800056

VL - 74

SP - 2333

EP - 2335

JO - Bioscience, Biotechnology and Biochemistry

JF - Bioscience, Biotechnology and Biochemistry

SN - 0916-8451

IS - 11

ER -